Chronic Pain Clinical Trial
— PNEOfficial title:
The Effectiveness of Training Physical Therapists in Pain Neuroscience Education on Patient Reported Outcomes for Patients With Chronic Spinal Pain
NCT number | NCT03168165 |
Other study ID # | 00097154 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 24, 2017 |
Est. completion date | June 1, 2019 |
Verified date | July 2020 |
Source | University of Utah |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a cluster randomized trial that involves training regions of physical therapy clinics to use pain neuroscience education or continue with usual care. The investigators will examine outcomes for patients with chronic neck or back pain.
Status | Completed |
Enrollment | 316 |
Est. completion date | June 1, 2019 |
Est. primary completion date | June 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age 18-75 at time of first physical therapy session - Primary reason for physical therapy is low back and/or neck pain - Meets the NIH definition of chronic pain (i.e., neck or back pain on at least half the days in the past 6 months.) Exclusion Criteria: - No spinal surgery within the previous 12 months - No evidence of "red flag" conditions (e.g., cauda equine syndrome, cancer, fracture, infection or systemic disease) that requires immediate referral from physical therapy to medical care - Not currently known to be pregnant |
Country | Name | City | State |
---|---|---|---|
United States | Benchmark Physical Therapy | Acworth | Georgia |
United States | BenchMark | Alpharetta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Atlanta | Georgia |
United States | BenchMark | Austell | Georgia |
United States | BenchMark | Birmingham | Alabama |
United States | BenchMark | Birmingham | Alabama |
United States | BenchMark | Canton | Georgia |
United States | BenchMark | Canton | Georgia |
United States | BenchMark | Carrollton | Georgia |
United States | BenchMark | Cartersville | Georgia |
United States | BenchMark | Columbus | Georgia |
United States | BenchMark | Dallas | Georgia |
United States | BenchMark | Decatur | Georgia |
United States | BenchMark | Dunwoody | Georgia |
United States | BenchMark | Helena | Alabama |
United States | BenchMark | Hiram | Georgia |
United States | BenchMark | Hoover | Alabama |
United States | BenchMark | Jasper | Georgia |
United States | BenchMark | Kennesaw | Georgia |
United States | Rehab South | Lawrenceville | Georgia |
United States | BenchMark | Marietta | Georgia |
United States | BenchMark | Marietta | Georgia |
United States | BenchMark | Marietta | Georgia |
United States | BenchMark | Marietta | Georgia |
United States | BenchMark | Marietta | Georgia |
United States | BenchMark | Moody | Alabama |
United States | Rehab South | Newnan | Georgia |
United States | BenchMark | Peachtree City | Georgia |
United States | Rehab South | Peachtree City | Georgia |
United States | BenchMark | Phenix City | Alabama |
United States | BenchMark | Roswell | Georgia |
United States | BenchMark | Roswell | Georgia |
United States | BenchMark | Roswell | Georgia |
United States | BenchMark | Smyrna | Georgia |
United States | BenchMark | Suwanee | Georgia |
United States | BenchMark | Tucker | Georgia |
Lead Sponsor | Collaborator |
---|---|
University of Utah |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function | Change score of Physical Function scores from baseline | 2 week and 12 week | |
Secondary | Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference | Change score of Pain Interference scores from baseline | 2 week and 12 week | |
Secondary | pain self-efficacy | Measured by Pain Self-Efficacy Questionnaire | 2 week and 12 week | |
Secondary | Autonomous motivation | Measured by Treatment Self-regulation Questionnaire | 2 week and 12 week | |
Secondary | Therapeutic Alliance | As measured by Working Alliance Theory of Change Inventory | 2 week and 12 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|